ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Operating margin 2015–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) operating margin by fiscal year — reported operating income divided by reported revenue.
-38.6%FY2024 · since FY2015: -249.6% → -38.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -38.6% | +193.2 pp |
| FY2023 | -231.8% | +372.2 pp |
| FY2022 | -604.0% | +2034.6 pp |
| FY2021 | -2638.6% | +731.9 pp |
| FY2020 | -3370.5% | +9086.7 pp |
| FY2019 | -12457.2% | -12318.8 pp |
| FY2018 | -138.4% | +74.8 pp |
| FY2017 | -213.2% | +299.5 pp |
| FY2016 | -512.7% | -263.1 pp |
| FY2015 | -249.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice